From the initial studies addressing the possibility to culture and profile gut microbiota communities (47), the field has developed to describe the core human gut microbiota (812), its tremendous genetic potential (100 times larger than the human genome) (10, 13) and variations according to geographical location (14, 15), ethnicity (16, 17) and disease status (18), including T2D (19, 20)
When utilizing a GLP-1 Lafayette patients may also see improvements in metabolic health parameters such as glycemic control, insulin sensitivity, blood pressure, and lipid profile
Lower prices may come at the expense of quality assurance and patient safety
Opt for healthy unsaturated fats (e.g., olive oil, avocado, fatty fish), which slow digestion and may enhance GLP-1 release
Current formulary entry and weight-management benefit language
Sometimes reducing the dose temporarily, or splitting the dose across the week , can maintain efficacy while reducing side effects